Abbott’s investigational Absorb™ Bioresorbable Vascular Scaffold was recently named one of R&D Magazine’s 2013 top 100 technologies as part of its 51st annual R&D 100 Awards. Absorb joins a number of innovative technologies being honored by the awards, which recognize the 100 most technologically significant products introduced into the marketplace over the past year. The full list of this year’s winners can be viewed on R&D Magazine’s website.

About the Absorb Bioresorbable Vascular Scaffold
The Absorb Bioresorbable Vascular Scaffold, similar to a small mesh tube, is designed to open a blocked heart vessel and restore blood flow to the heart. Absorb is referred to as a scaffold to indicate that it is a temporary structure, unlike a metallic stent, which is a permanent implant. The scaffold provides support to the vessel until the artery can stay open on its own, and then dissolves naturally over time. Absorb completely dissolves except for two pairs of tiny metallic markers, which help guide placement and remain in the artery to enable a physician to see where the device was placed.